Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “glp1 Agonist”

306 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 306 results

Testing effectiveness (Phase 2)Study completedNCT06867718
What this trial is testing

Study of Once-Daily Oral RGT001-075 Compared With Placebo in Adults With Obesity or Are Overweight With Weight-Related Health Conditions

Who this might be right for
Obesity or Overweight
Regor Pharmaceuticals Inc. 267
Not applicableLooking for participantsNCT07625202
What this trial is testing

Creatine Supplementation During GLP-1a Therapy

Who this might be right for
Sarcopenia
University of Saskatchewan 40
Post-approval studies (Phase 4)Study completedNCT02686177
What this trial is testing

Effect of GLP-1 on Angiogenesis

Who this might be right for
Type 2 Diabetes
Assistance Publique - Hôpitaux de Paris 50
Not applicableLooking for participantsNCT07760896
What this trial is testing

The GLOW Study: GLP-1 and Lifestyle for Optimal Wellness

Who this might be right for
Wellness
Saundra Jain 200
Early research (Phase 1)Study completedNCT05444569
What this trial is testing

LY3537021 in Healthy Participants

Who this might be right for
Healthy
Eli Lilly and Company 47
Post-approval studies (Phase 4)Not Yet RecruitingNCT07630454
What this trial is testing

Tirzepatide on Atrial Fibrillation Recurrence After Catheter Ablation in Patients With Obesity and HFpEF

Who this might be right for
Atrial FibrillationHeart Failure With Preserved Ejection Fraction (HFpEF)Tirzepatide
Yunlong Wang 602
Post-approval studies (Phase 4)Looking for participantsNCT06671587
What this trial is testing

IGlarLixi CGM Study in Chinese T2D Individuals After OADs

Who this might be right for
Type 2 Diabetes (T2D)
Sanofi 678
Large-scale testing (Phase 3)Study completedNCT05260021
What this trial is testing

Evaluate Tirzepatide (LY3298176) in Pediatric and Adolescent Participants With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin or Basal Insulin or Both

Who this might be right for
Type2 DiabetesDiabetes MellitusDiabetes Mellitus, Type 2+5 more
Eli Lilly and Company 99
Not applicableStudy completedNCT07096739
What this trial is testing

Tolerance of a High Protein Nutrition Shake in Individuals on GLP-1

Who this might be right for
GLP-1 Concentration
Kate Farms Inc 20
Post-approval studies (Phase 4)Study completedNCT01899430
What this trial is testing

Polycystic Ovary Syndrome and Liraglutide

Who this might be right for
PCOSObesity
University Medical Centre Ljubljana 32
Early research (Phase 1)Study completedNCT05882032
What this trial is testing

LY3502970 in Participants With Impaired and Normal Liver Function

Who this might be right for
HealthyHepatic Insufficiency
Eli Lilly and Company 29
Not applicableActive Not RecruitingNCT06467604
What this trial is testing

CRAVE Study: Comparing Craving Responses and Diet Quality of GLP1 Receptor Agonist Users

Who this might be right for
Obesity
University of California, Davis 7
Post-approval studies (Phase 4)UnknownNCT04029272
What this trial is testing

Metformin vs Metformin Combined With GLP-1RA (Glucagon-like Peptide 1 Receptor Agonist) on Overweight/Obese PCOS Patients

Who this might be right for
Polycystic Ovary Syndrome
Peking Union Medical College Hospital 80
Testing effectiveness (Phase 2)UnknownNCT05659368
What this trial is testing

Tirzepatide Monotherapy in Patients With Wolfram Syndrome Type 1

Who this might be right for
Wolfram Syndrome
Ospedale San Raffaele 10
Very early researchLooking for participantsNCT07627191
What this trial is testing

GLP-1 RA Plus SOC Treatment in First-line, Metastatic Pancreatic, Colorectal, or Hepatocellular Cancer

Who this might be right for
Pancreatic CancerColorectal CancerHepatocellular Carcinoma
University of Arizona 30
Not applicableLooking for participantsNCT07293325
What this trial is testing

Semaglutide and Tirzepatide for Genetic Aging Delay in Adults With Obesity

Who this might be right for
Adults With Simple Obesity
Second Affiliated Hospital, Zhejiang University, School of Medicine 66
Not applicableNot Yet RecruitingNCT07708610
What this trial is testing

Preadmission GLP-1 Receptor Agonist Plus SGLT2 Inhibitor Use and Early Outcomes After Pneumonia Hospitalization in Adults With Type 2 Diabetes

Who this might be right for
PneumoniaType 2 Diabetes Mellitus (T2DM)
Chung Shan Medical University 71,775
Post-approval studies (Phase 4)Looking for participantsNCT07718126
What this trial is testing

Pre-hepatectomy Rehabilitation in Obese MASLD-Complicated Living Liver Donors With Mazdutide (PRIME)

Who this might be right for
Metabolic Dysfunction-Associated SteatohepatitisHepatic SteatosisLiving Liver Donors
West China Hospital 60
Post-approval studies (Phase 4)Active Not RecruitingNCT07325435
What this trial is testing

Beta Cell Function in Type 2 Diabetes: Differential Effects of SGLT2 Inhibitors and GLIP-Receptor Agonists

Who this might be right for
Type 2 Diabetes (T2DM)
MaryAnn Banerji 60
Post-approval studies (Phase 4)Not Yet RecruitingNCT07547878
What this trial is testing

Rapid and Simultaneous Initiation of Four Guideline-Directed CKD Therapies (RAPID-CKD)

Who this might be right for
Chronic Kidney DiseaseType 2 Diabetes
Baylor Research Institute 64
Next Page